Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2013-04-24

AUTHORS

E. Garin, L. Lenoir, J. Edeline, S. Laffont, H. Mesbah, P. Porée, L. Sulpice, K. Boudjema, M. Mesbah, A. Guillygomarc’h, E. Quehen, M. Pracht, J. L. Raoul, B. Clement, Y. Rolland, E. Boucher

ABSTRACT

PURPOSE: To evaluate the impact of dosimetry based on MAA SPECT/CT for the prediction of response, toxicity and survival, and for treatment planning in patients with hepatocellular carcinoma (HCC) treated with (90)Y-loaded glass microspheres (TheraSphere®). METHODS: TheraSphere® was administered to 71 patients with inoperable HCC. MAA SPECT/CT quantitative analysis was used for the calculation of the tumour dose (TD), healthy injected liver dose (HILD), and total injected liver dose. Response was evaluated at 3 months using EASL criteria. Time to progression (TTP) and overall survival (OS) were evaluated using the Kaplan-Meier method. Factors potentially associated with liver toxicity were combined to construct a liver toxicity score (LTS). RESULTS: The response rate was 78.8%. Median TD were 342 Gy for responding lesions and 191 Gy for nonresponding lesions (p < 0.001). With a threshold TD of 205 Gy, MAA SPECT/CT predicted response with a sensitivity of 100% and overall accuracy of 90%. Based on TD and HILD, 17 patients underwent treatment intensification resulting in a good response rate (76.4%), without increased grade III liver toxicity. The median TTP and OS were 5.5 months (2-9.5 months) and 11.5 months (2-31 months), respectively, in patients with TD <205 Gy and 13 months (10-16 months) and 23.2 months (17.5-28.5 months), respectively, in those with TD >205 Gy (p = 0.0015 and not significant). Among patients with portal vein thrombosis (PVT) (n = 33), the median TTP and OS were 4.5 months (2-7 months) and 5 months (2-8 months), respectively, in patients with TD <205 Gy and 10 months (6-15.2 months) and 21.5 months (12-28.5 months), respectively, in those with TD >205 Gy (p = 0.039 and 0.005). The median OS was 24.5 months (18-28.5 months) in PVT patients with TD >205 Gy and good PVT targeting on MAA SPECT/CT. The LTS was able to detect severe liver toxicity (n = 6) with a sensitivity of 83% and overall accuracy of 97%. CONCLUSION: Dosimetry based on MAA SPECT/CT was able to accurately predict response and survival in patients treated with glass microspheres. This method can be used to adapt the injected activity without increasing liver toxicity, thus defining a new concept of boosted selective internal radiation therapy (B-SIRT). This new concept and LTS enable fully personalized treatment planning with glass microspheres to be achieved. More... »

PAGES

1057-1068

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00259-013-2395-x

DOI

http://dx.doi.org/10.1007/s00259-013-2395-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1029028591

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23613103


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Hepatocellular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glass", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Microspheres", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Precision Medicine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiometry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy Planning, Computer-Assisted", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Safety", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tomography, Emission-Computed, Single-Photon", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tomography, X-Ray Computed", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Yttrium Radioisotopes", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "INSERM, U-991, Liver Metabolisms and Cancer, F-35033 Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.462725.0", 
          "name": [
            "Department of Nuclear Medicine, CS 44229, Comprehensive Cancer Center, Institute Eug\u00e8ne Marquis, F-35042 Rennes, France", 
            "University of Rennes 1, F-35043 Rennes, France", 
            "INSERM, U-991, Liver Metabolisms and Cancer, F-35033 Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Garin", 
        "givenName": "E.", 
        "id": "sg:person.0620512077.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620512077.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "INSERM, U-991, Liver Metabolisms and Cancer, F-35033 Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.462725.0", 
          "name": [
            "Department of Nuclear Medicine, CS 44229, Comprehensive Cancer Center, Institute Eug\u00e8ne Marquis, F-35042 Rennes, France", 
            "University of Rennes 1, F-35043 Rennes, France", 
            "INSERM, U-991, Liver Metabolisms and Cancer, F-35033 Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lenoir", 
        "givenName": "L.", 
        "id": "sg:person.0637666632.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637666632.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, CS 44229, Comprehensive Cancer Center, Institute Eug\u00e8ne Marquis, 35042 Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.418189.d", 
          "name": [
            "University of Rennes 1, F-35043 Rennes, France", 
            "Department of Medical Oncology, CS 44229, Comprehensive Cancer Center, Institute Eug\u00e8ne Marquis, 35042 Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Edeline", 
        "givenName": "J.", 
        "id": "sg:person.0657306623.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657306623.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, CS 44229, Comprehensive Cancer Center, Institute Eug\u00e8ne Marquis, F-35042 Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.418189.d", 
          "name": [
            "Department of Nuclear Medicine, CS 44229, Comprehensive Cancer Center, Institute Eug\u00e8ne Marquis, F-35042 Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Laffont", 
        "givenName": "S.", 
        "id": "sg:person.0613252755.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613252755.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Informatics, CS 44229, Comprehensive Cancer Center, Institute Eug\u00e8ne Marquis, 35042 Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.418189.d", 
          "name": [
            "Department of Medical Informatics, CS 44229, Comprehensive Cancer Center, Institute Eug\u00e8ne Marquis, 35042 Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mesbah", 
        "givenName": "H.", 
        "id": "sg:person.0757022007.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757022007.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Informatics, CS 44229, Comprehensive Cancer Center, Institute Eug\u00e8ne Marquis, 35042 Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.418189.d", 
          "name": [
            "Department of Medical Informatics, CS 44229, Comprehensive Cancer Center, Institute Eug\u00e8ne Marquis, 35042 Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Por\u00e9e", 
        "givenName": "P.", 
        "id": "sg:person.0744253057.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744253057.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Digestive Surgery, Centre Hospitalier Universitaire Pontchaillou, 35033 Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.414271.5", 
          "name": [
            "INSERM, U-991, Liver Metabolisms and Cancer, F-35033 Rennes, France", 
            "Department of Digestive Surgery, Centre Hospitalier Universitaire Pontchaillou, 35033 Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sulpice", 
        "givenName": "L.", 
        "id": "sg:person.0722245240.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722245240.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Digestive Surgery, Centre Hospitalier Universitaire Pontchaillou, 35033 Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.414271.5", 
          "name": [
            "University of Rennes 1, F-35043 Rennes, France", 
            "INSERM, U-991, Liver Metabolisms and Cancer, F-35033 Rennes, France", 
            "Department of Digestive Surgery, Centre Hospitalier Universitaire Pontchaillou, 35033 Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boudjema", 
        "givenName": "K.", 
        "id": "sg:person.01364777013.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364777013.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pierre et Marie Curie, 75005 Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.462844.8", 
          "name": [
            "University of Pierre et Marie Curie, 75005 Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mesbah", 
        "givenName": "M.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hepatology, Centre Hospitalier Universitaire Pontchaillou, 35033 Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.414271.5", 
          "name": [
            "Department of Hepatology, Centre Hospitalier Universitaire Pontchaillou, 35033 Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guillygomarc\u2019h", 
        "givenName": "A.", 
        "id": "sg:person.01074300205.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074300205.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiology, Centre Hospitalier Universitaire Pontchaillou, 35033 Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.414271.5", 
          "name": [
            "Department of Radiology, Centre Hospitalier Universitaire Pontchaillou, 35033 Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Quehen", 
        "givenName": "E.", 
        "id": "sg:person.0606344634.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606344634.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, CS 44229, Comprehensive Cancer Center, Institute Eug\u00e8ne Marquis, 35042 Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.418189.d", 
          "name": [
            "Department of Medical Oncology, CS 44229, Comprehensive Cancer Center, Institute Eug\u00e8ne Marquis, 35042 Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pracht", 
        "givenName": "M.", 
        "id": "sg:person.01363611400.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01363611400.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Comprehensive Cancer Center, Institute Paoli Calmette, 13273 Marseille, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Medical Oncology, Comprehensive Cancer Center, Institute Paoli Calmette, 13273 Marseille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Raoul", 
        "givenName": "J. L.", 
        "id": "sg:person.0617474270.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617474270.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "INSERM, U-991, Liver Metabolisms and Cancer, F-35033 Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.462725.0", 
          "name": [
            "INSERM, U-991, Liver Metabolisms and Cancer, F-35033 Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Clement", 
        "givenName": "B.", 
        "id": "sg:person.01116665131.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116665131.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Imaging, CS 44229, Comprehensive Cancer Center, Institute Eug\u00e8ne Marquis, 35042 Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.418189.d", 
          "name": [
            "Department of Medical Imaging, CS 44229, Comprehensive Cancer Center, Institute Eug\u00e8ne Marquis, 35042 Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rolland", 
        "givenName": "Y.", 
        "id": "sg:person.01014347637.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014347637.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, CS 44229, Comprehensive Cancer Center, Institute Eug\u00e8ne Marquis, 35042 Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.418189.d", 
          "name": [
            "INSERM, U-991, Liver Metabolisms and Cancer, F-35033 Rennes, France", 
            "Department of Medical Oncology, CS 44229, Comprehensive Cancer Center, Institute Eug\u00e8ne Marquis, 35042 Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boucher", 
        "givenName": "E.", 
        "id": "sg:person.0665747347.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0665747347.57"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00259-008-0857-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005187311", 
          "https://doi.org/10.1007/s00259-008-0857-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01728766", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007717683", 
          "https://doi.org/10.1007/bf01728766"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-04-24", 
    "datePublishedReg": "2013-04-24", 
    "description": "PURPOSE: To evaluate the impact of dosimetry based on MAA SPECT/CT for the prediction of response, toxicity and survival, and for treatment planning in patients with hepatocellular carcinoma (HCC) treated with (90)Y-loaded glass microspheres (TheraSphere\u00ae).\nMETHODS: TheraSphere\u00ae was administered to 71 patients with inoperable HCC. MAA SPECT/CT quantitative analysis was used for the calculation of the tumour dose (TD), healthy injected liver dose (HILD), and total injected liver dose. Response was evaluated at 3 months using EASL criteria. Time to progression (TTP) and overall survival (OS) were evaluated using the Kaplan-Meier method. Factors potentially associated with liver toxicity were combined to construct a liver toxicity score (LTS).\nRESULTS: The response rate was 78.8%. Median TD were 342 Gy for responding lesions and 191 Gy for nonresponding lesions (p < 0.001). With a threshold TD of 205 Gy, MAA SPECT/CT predicted response with a sensitivity of 100% and overall accuracy of 90%. Based on TD and HILD, 17 patients underwent treatment intensification resulting in a good response rate (76.4%), without increased grade III liver toxicity. The median TTP and OS were 5.5 months (2-9.5 months) and 11.5 months (2-31 months), respectively, in patients with TD <205 Gy and 13 months (10-16 months) and 23.2 months (17.5-28.5 months), respectively, in those with TD >205 Gy (p = 0.0015 and not significant). Among patients with portal vein thrombosis (PVT) (n = 33), the median TTP and OS were 4.5 months (2-7 months) and 5 months (2-8 months), respectively, in patients with TD <205 Gy and 10 months (6-15.2 months) and 21.5 months (12-28.5 months), respectively, in those with TD >205 Gy (p = 0.039 and 0.005). The median OS was 24.5 months (18-28.5 months) in PVT patients with TD >205 Gy and good PVT targeting on MAA SPECT/CT. The LTS was able to detect severe liver toxicity (n = 6) with a sensitivity of 83% and overall accuracy of 97%.\nCONCLUSION: Dosimetry based on MAA SPECT/CT was able to accurately predict response and survival in patients treated with glass microspheres. This method can be used to adapt the injected activity without increasing liver toxicity, thus defining a new concept of boosted selective internal radiation therapy (B-SIRT). This new concept and LTS enable fully personalized treatment planning with glass microspheres to be achieved.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00259-013-2395-x", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "40"
      }
    ], 
    "keywords": [
      "healthy injected liver dose", 
      "MAA SPECT/CT", 
      "portal vein thrombosis", 
      "SPECT/CT", 
      "selective internal radiation therapy", 
      "overall survival", 
      "tumor dose", 
      "internal radiation therapy", 
      "liver toxicity", 
      "hepatocellular carcinoma", 
      "median TTP", 
      "liver dose", 
      "radiation therapy", 
      "response rate", 
      "median tumor dose", 
      "median overall survival", 
      "inoperable hepatocellular carcinoma", 
      "Kaplan-Meier method", 
      "severe liver toxicity", 
      "hepatocellular carcinoma patients", 
      "better response rate", 
      "impact of dosimetry", 
      "CT quantitative analysis", 
      "prediction of response", 
      "PVT patients", 
      "treatment intensification", 
      "vein thrombosis", 
      "EASL criteria", 
      "carcinoma patients", 
      "patients", 
      "injected activity", 
      "toxicity scores", 
      "months", 
      "CT", 
      "dose", 
      "treatment planning", 
      "survival", 
      "therapy", 
      "lesions", 
      "toxicity", 
      "Gy", 
      "TTP", 
      "response", 
      "TheraSphere", 
      "thrombosis", 
      "carcinoma", 
      "progression", 
      "overall accuracy", 
      "treatment", 
      "scores", 
      "sensitivity", 
      "rate", 
      "dosimetry", 
      "factors", 
      "criteria", 
      "activity", 
      "microspheres", 
      "quantitative analysis", 
      "glass microspheres", 
      "new concept", 
      "promising concept", 
      "time", 
      "impact", 
      "method", 
      "analysis", 
      "planning", 
      "accuracy", 
      "concept", 
      "intensification", 
      "prediction", 
      "calculations", 
      "MAA SPECT/CT quantitative analysis", 
      "SPECT/CT quantitative analysis", 
      "injected liver dose", 
      "total injected liver dose", 
      "LTS", 
      "threshold TD", 
      "grade III liver toxicity", 
      "III liver toxicity", 
      "good PVT", 
      "new personalized promising concept", 
      "personalized promising concept"
    ], 
    "name": "Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept", 
    "pagination": "1057-1068", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1029028591"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00259-013-2395-x"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23613103"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00259-013-2395-x", 
      "https://app.dimensions.ai/details/publication/pub.1029028591"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:30", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_597.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00259-013-2395-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00259-013-2395-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00259-013-2395-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00259-013-2395-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00259-013-2395-x'


 

This table displays all metadata directly associated to this object as RDF triples.

360 TRIPLES      22 PREDICATES      129 URIs      119 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00259-013-2395-x schema:about N0187dc7259214052996fa7b58b08d9b5
2 N0ed230cd9294474b90ca64599265bebd
3 N16891a3e746147f9979b72670e6db62b
4 N22b83018c4f34f65ac0a48050c762826
5 N34588cc65eb84571aedf0279c317b059
6 N3700857aa65f49acbad987d99e715e35
7 N56851c5b15d84b519d1d9bc9dd2c3bc4
8 N68387c75a3544cf78e572bc1d0f7afe3
9 N6af03c7394f44aacb34d6da28f0f59af
10 N6fa11684d44f41c58dd1e2ce720f04b1
11 N7593011267b24fab91b706609d603be1
12 N7d8c1b82a9fc4f0490bb5bc1dbaa3487
13 N965eb66a3ae2404792754b1d8ddbbab3
14 N9cb7aa8e7b2445e9bb65c3052e7523dc
15 Nb1b398eb8d9a424b89202365696f02ed
16 Nb45e830fa2b145e7a1d7097a76cc0ec0
17 Nc87404cf3f294c1eb658d8b5ae0ff6d9
18 Ndbb82ab714b649ad952e2b3c7b2ec713
19 Ne012dfa7f5ba4c648ce504cc04cf6dad
20 anzsrc-for:11
21 anzsrc-for:1112
22 schema:author N3c6a3dde8684424faafb4d84f67f71d7
23 schema:citation sg:pub.10.1007/bf01728766
24 sg:pub.10.1007/s00259-008-0857-3
25 schema:datePublished 2013-04-24
26 schema:datePublishedReg 2013-04-24
27 schema:description PURPOSE: To evaluate the impact of dosimetry based on MAA SPECT/CT for the prediction of response, toxicity and survival, and for treatment planning in patients with hepatocellular carcinoma (HCC) treated with (90)Y-loaded glass microspheres (TheraSphere®). METHODS: TheraSphere® was administered to 71 patients with inoperable HCC. MAA SPECT/CT quantitative analysis was used for the calculation of the tumour dose (TD), healthy injected liver dose (HILD), and total injected liver dose. Response was evaluated at 3 months using EASL criteria. Time to progression (TTP) and overall survival (OS) were evaluated using the Kaplan-Meier method. Factors potentially associated with liver toxicity were combined to construct a liver toxicity score (LTS). RESULTS: The response rate was 78.8%. Median TD were 342 Gy for responding lesions and 191 Gy for nonresponding lesions (p < 0.001). With a threshold TD of 205 Gy, MAA SPECT/CT predicted response with a sensitivity of 100% and overall accuracy of 90%. Based on TD and HILD, 17 patients underwent treatment intensification resulting in a good response rate (76.4%), without increased grade III liver toxicity. The median TTP and OS were 5.5 months (2-9.5 months) and 11.5 months (2-31 months), respectively, in patients with TD <205 Gy and 13 months (10-16 months) and 23.2 months (17.5-28.5 months), respectively, in those with TD >205 Gy (p = 0.0015 and not significant). Among patients with portal vein thrombosis (PVT) (n = 33), the median TTP and OS were 4.5 months (2-7 months) and 5 months (2-8 months), respectively, in patients with TD <205 Gy and 10 months (6-15.2 months) and 21.5 months (12-28.5 months), respectively, in those with TD >205 Gy (p = 0.039 and 0.005). The median OS was 24.5 months (18-28.5 months) in PVT patients with TD >205 Gy and good PVT targeting on MAA SPECT/CT. The LTS was able to detect severe liver toxicity (n = 6) with a sensitivity of 83% and overall accuracy of 97%. CONCLUSION: Dosimetry based on MAA SPECT/CT was able to accurately predict response and survival in patients treated with glass microspheres. This method can be used to adapt the injected activity without increasing liver toxicity, thus defining a new concept of boosted selective internal radiation therapy (B-SIRT). This new concept and LTS enable fully personalized treatment planning with glass microspheres to be achieved.
28 schema:genre article
29 schema:inLanguage en
30 schema:isAccessibleForFree true
31 schema:isPartOf Nae6489a0a02e4a5bbdc1ed6b7c87a3b5
32 Ne4c6f8b4f1384b789fe06797edc3e2a0
33 sg:journal.1297401
34 schema:keywords CT
35 CT quantitative analysis
36 EASL criteria
37 Gy
38 III liver toxicity
39 Kaplan-Meier method
40 LTS
41 MAA SPECT/CT
42 MAA SPECT/CT quantitative analysis
43 PVT patients
44 SPECT/CT
45 SPECT/CT quantitative analysis
46 TTP
47 TheraSphere
48 accuracy
49 activity
50 analysis
51 better response rate
52 calculations
53 carcinoma
54 carcinoma patients
55 concept
56 criteria
57 dose
58 dosimetry
59 factors
60 glass microspheres
61 good PVT
62 grade III liver toxicity
63 healthy injected liver dose
64 hepatocellular carcinoma
65 hepatocellular carcinoma patients
66 impact
67 impact of dosimetry
68 injected activity
69 injected liver dose
70 inoperable hepatocellular carcinoma
71 intensification
72 internal radiation therapy
73 lesions
74 liver dose
75 liver toxicity
76 median TTP
77 median overall survival
78 median tumor dose
79 method
80 microspheres
81 months
82 new concept
83 new personalized promising concept
84 overall accuracy
85 overall survival
86 patients
87 personalized promising concept
88 planning
89 portal vein thrombosis
90 prediction
91 prediction of response
92 progression
93 promising concept
94 quantitative analysis
95 radiation therapy
96 rate
97 response
98 response rate
99 scores
100 selective internal radiation therapy
101 sensitivity
102 severe liver toxicity
103 survival
104 therapy
105 threshold TD
106 thrombosis
107 time
108 total injected liver dose
109 toxicity
110 toxicity scores
111 treatment
112 treatment intensification
113 treatment planning
114 tumor dose
115 vein thrombosis
116 schema:name Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept
117 schema:pagination 1057-1068
118 schema:productId N817fa0570aea4664bab449aa85eb2f68
119 Nb199bd883f244d64a05c82123422a819
120 Ne7e4f17b233b4ccba061d92a139b22ea
121 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029028591
122 https://doi.org/10.1007/s00259-013-2395-x
123 schema:sdDatePublished 2022-01-01T18:30
124 schema:sdLicense https://scigraph.springernature.com/explorer/license/
125 schema:sdPublisher Nafce5833371e459382dc0290939c7a5e
126 schema:url https://doi.org/10.1007/s00259-013-2395-x
127 sgo:license sg:explorer/license/
128 sgo:sdDataset articles
129 rdf:type schema:ScholarlyArticle
130 N0187dc7259214052996fa7b58b08d9b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Precision Medicine
132 rdf:type schema:DefinedTerm
133 N0d420cb618eb48158d23daadccdcc011 rdf:first sg:person.0744253057.58
134 rdf:rest Na7e11a2632db49738571d2f6730b8997
135 N0ed230cd9294474b90ca64599265bebd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Radiometry
137 rdf:type schema:DefinedTerm
138 N16891a3e746147f9979b72670e6db62b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Microspheres
140 rdf:type schema:DefinedTerm
141 N22b83018c4f34f65ac0a48050c762826 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Survival Analysis
143 rdf:type schema:DefinedTerm
144 N2e56b3e8d9ad458f9c782bcb93bff652 rdf:first sg:person.0757022007.25
145 rdf:rest N0d420cb618eb48158d23daadccdcc011
146 N34588cc65eb84571aedf0279c317b059 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Tomography, Emission-Computed, Single-Photon
148 rdf:type schema:DefinedTerm
149 N347f96c332f445499626e044971f8fd8 rdf:first sg:person.0657306623.46
150 rdf:rest N42a2dbbdee3c473995d422487813d387
151 N36883bcac2fc4d768ee97052c7b5fcda rdf:first sg:person.01364777013.76
152 rdf:rest N8cbd994d4a874912ac60725bcf6760e1
153 N3700857aa65f49acbad987d99e715e35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Liver Neoplasms
155 rdf:type schema:DefinedTerm
156 N3a2b7d79f7514c1f8d8e4faab8d43c2c rdf:first sg:person.01116665131.63
157 rdf:rest N94f2fdcd48c64b609bd128e4688dd071
158 N3c6a3dde8684424faafb4d84f67f71d7 rdf:first sg:person.0620512077.06
159 rdf:rest Ne486c61ceee341c5a9542e1ff1feec5c
160 N3d5d3eff2c4a41dfaf384b3878e5ffe9 rdf:first sg:person.0665747347.57
161 rdf:rest rdf:nil
162 N42a2dbbdee3c473995d422487813d387 rdf:first sg:person.0613252755.07
163 rdf:rest N2e56b3e8d9ad458f9c782bcb93bff652
164 N4533e7b597cf4dffb5a2ecabe5d70c95 rdf:first sg:person.0617474270.02
165 rdf:rest N3a2b7d79f7514c1f8d8e4faab8d43c2c
166 N4e4981b4e1da4c139d0a53022b82dbae rdf:first sg:person.01363611400.69
167 rdf:rest N4533e7b597cf4dffb5a2ecabe5d70c95
168 N560b5718caef463280f9146021a4e792 schema:affiliation grid-institutes:grid.462844.8
169 schema:familyName Mesbah
170 schema:givenName M.
171 rdf:type schema:Person
172 N56851c5b15d84b519d1d9bc9dd2c3bc4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Carcinoma, Hepatocellular
174 rdf:type schema:DefinedTerm
175 N68387c75a3544cf78e572bc1d0f7afe3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Retrospective Studies
177 rdf:type schema:DefinedTerm
178 N6af03c7394f44aacb34d6da28f0f59af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Glass
180 rdf:type schema:DefinedTerm
181 N6fa11684d44f41c58dd1e2ce720f04b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Humans
183 rdf:type schema:DefinedTerm
184 N7593011267b24fab91b706609d603be1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Yttrium Radioisotopes
186 rdf:type schema:DefinedTerm
187 N7d8c1b82a9fc4f0490bb5bc1dbaa3487 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Male
189 rdf:type schema:DefinedTerm
190 N817fa0570aea4664bab449aa85eb2f68 schema:name pubmed_id
191 schema:value 23613103
192 rdf:type schema:PropertyValue
193 N8cbd994d4a874912ac60725bcf6760e1 rdf:first N560b5718caef463280f9146021a4e792
194 rdf:rest Ncd8034a66c7044bebb46a58a5fdb7e52
195 N94f2fdcd48c64b609bd128e4688dd071 rdf:first sg:person.01014347637.31
196 rdf:rest N3d5d3eff2c4a41dfaf384b3878e5ffe9
197 N965eb66a3ae2404792754b1d8ddbbab3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Tomography, X-Ray Computed
199 rdf:type schema:DefinedTerm
200 N9cb7aa8e7b2445e9bb65c3052e7523dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Treatment Outcome
202 rdf:type schema:DefinedTerm
203 N9d820b383d77494382d33a4d982fb6af rdf:first sg:person.0606344634.05
204 rdf:rest N4e4981b4e1da4c139d0a53022b82dbae
205 Na7e11a2632db49738571d2f6730b8997 rdf:first sg:person.0722245240.56
206 rdf:rest N36883bcac2fc4d768ee97052c7b5fcda
207 Nae6489a0a02e4a5bbdc1ed6b7c87a3b5 schema:volumeNumber 40
208 rdf:type schema:PublicationVolume
209 Nafce5833371e459382dc0290939c7a5e schema:name Springer Nature - SN SciGraph project
210 rdf:type schema:Organization
211 Nb199bd883f244d64a05c82123422a819 schema:name doi
212 schema:value 10.1007/s00259-013-2395-x
213 rdf:type schema:PropertyValue
214 Nb1b398eb8d9a424b89202365696f02ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
215 schema:name Female
216 rdf:type schema:DefinedTerm
217 Nb45e830fa2b145e7a1d7097a76cc0ec0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
218 schema:name Middle Aged
219 rdf:type schema:DefinedTerm
220 Nc87404cf3f294c1eb658d8b5ae0ff6d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
221 schema:name Safety
222 rdf:type schema:DefinedTerm
223 Ncd8034a66c7044bebb46a58a5fdb7e52 rdf:first sg:person.01074300205.48
224 rdf:rest N9d820b383d77494382d33a4d982fb6af
225 Ndbb82ab714b649ad952e2b3c7b2ec713 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
226 schema:name Liver
227 rdf:type schema:DefinedTerm
228 Ne012dfa7f5ba4c648ce504cc04cf6dad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
229 schema:name Radiotherapy Planning, Computer-Assisted
230 rdf:type schema:DefinedTerm
231 Ne486c61ceee341c5a9542e1ff1feec5c rdf:first sg:person.0637666632.85
232 rdf:rest N347f96c332f445499626e044971f8fd8
233 Ne4c6f8b4f1384b789fe06797edc3e2a0 schema:issueNumber 7
234 rdf:type schema:PublicationIssue
235 Ne7e4f17b233b4ccba061d92a139b22ea schema:name dimensions_id
236 schema:value pub.1029028591
237 rdf:type schema:PropertyValue
238 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
239 schema:name Medical and Health Sciences
240 rdf:type schema:DefinedTerm
241 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
242 schema:name Oncology and Carcinogenesis
243 rdf:type schema:DefinedTerm
244 sg:journal.1297401 schema:issn 1619-7070
245 1619-7089
246 schema:name European Journal of Nuclear Medicine and Molecular Imaging
247 schema:publisher Springer Nature
248 rdf:type schema:Periodical
249 sg:person.01014347637.31 schema:affiliation grid-institutes:grid.418189.d
250 schema:familyName Rolland
251 schema:givenName Y.
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014347637.31
253 rdf:type schema:Person
254 sg:person.01074300205.48 schema:affiliation grid-institutes:grid.414271.5
255 schema:familyName Guillygomarc’h
256 schema:givenName A.
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074300205.48
258 rdf:type schema:Person
259 sg:person.01116665131.63 schema:affiliation grid-institutes:grid.462725.0
260 schema:familyName Clement
261 schema:givenName B.
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116665131.63
263 rdf:type schema:Person
264 sg:person.01363611400.69 schema:affiliation grid-institutes:grid.418189.d
265 schema:familyName Pracht
266 schema:givenName M.
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01363611400.69
268 rdf:type schema:Person
269 sg:person.01364777013.76 schema:affiliation grid-institutes:grid.414271.5
270 schema:familyName Boudjema
271 schema:givenName K.
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364777013.76
273 rdf:type schema:Person
274 sg:person.0606344634.05 schema:affiliation grid-institutes:grid.414271.5
275 schema:familyName Quehen
276 schema:givenName E.
277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606344634.05
278 rdf:type schema:Person
279 sg:person.0613252755.07 schema:affiliation grid-institutes:grid.418189.d
280 schema:familyName Laffont
281 schema:givenName S.
282 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613252755.07
283 rdf:type schema:Person
284 sg:person.0617474270.02 schema:affiliation grid-institutes:None
285 schema:familyName Raoul
286 schema:givenName J. L.
287 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617474270.02
288 rdf:type schema:Person
289 sg:person.0620512077.06 schema:affiliation grid-institutes:grid.462725.0
290 schema:familyName Garin
291 schema:givenName E.
292 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620512077.06
293 rdf:type schema:Person
294 sg:person.0637666632.85 schema:affiliation grid-institutes:grid.462725.0
295 schema:familyName Lenoir
296 schema:givenName L.
297 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637666632.85
298 rdf:type schema:Person
299 sg:person.0657306623.46 schema:affiliation grid-institutes:grid.418189.d
300 schema:familyName Edeline
301 schema:givenName J.
302 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657306623.46
303 rdf:type schema:Person
304 sg:person.0665747347.57 schema:affiliation grid-institutes:grid.418189.d
305 schema:familyName Boucher
306 schema:givenName E.
307 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0665747347.57
308 rdf:type schema:Person
309 sg:person.0722245240.56 schema:affiliation grid-institutes:grid.414271.5
310 schema:familyName Sulpice
311 schema:givenName L.
312 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722245240.56
313 rdf:type schema:Person
314 sg:person.0744253057.58 schema:affiliation grid-institutes:grid.418189.d
315 schema:familyName Porée
316 schema:givenName P.
317 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744253057.58
318 rdf:type schema:Person
319 sg:person.0757022007.25 schema:affiliation grid-institutes:grid.418189.d
320 schema:familyName Mesbah
321 schema:givenName H.
322 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757022007.25
323 rdf:type schema:Person
324 sg:pub.10.1007/bf01728766 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007717683
325 https://doi.org/10.1007/bf01728766
326 rdf:type schema:CreativeWork
327 sg:pub.10.1007/s00259-008-0857-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005187311
328 https://doi.org/10.1007/s00259-008-0857-3
329 rdf:type schema:CreativeWork
330 grid-institutes:None schema:alternateName Department of Medical Oncology, Comprehensive Cancer Center, Institute Paoli Calmette, 13273 Marseille, France
331 schema:name Department of Medical Oncology, Comprehensive Cancer Center, Institute Paoli Calmette, 13273 Marseille, France
332 rdf:type schema:Organization
333 grid-institutes:grid.414271.5 schema:alternateName Department of Digestive Surgery, Centre Hospitalier Universitaire Pontchaillou, 35033 Rennes, France
334 Department of Hepatology, Centre Hospitalier Universitaire Pontchaillou, 35033 Rennes, France
335 Department of Radiology, Centre Hospitalier Universitaire Pontchaillou, 35033 Rennes, France
336 schema:name Department of Digestive Surgery, Centre Hospitalier Universitaire Pontchaillou, 35033 Rennes, France
337 Department of Hepatology, Centre Hospitalier Universitaire Pontchaillou, 35033 Rennes, France
338 Department of Radiology, Centre Hospitalier Universitaire Pontchaillou, 35033 Rennes, France
339 INSERM, U-991, Liver Metabolisms and Cancer, F-35033 Rennes, France
340 University of Rennes 1, F-35043 Rennes, France
341 rdf:type schema:Organization
342 grid-institutes:grid.418189.d schema:alternateName Department of Medical Imaging, CS 44229, Comprehensive Cancer Center, Institute Eugène Marquis, 35042 Rennes, France
343 Department of Medical Informatics, CS 44229, Comprehensive Cancer Center, Institute Eugène Marquis, 35042 Rennes, France
344 Department of Medical Oncology, CS 44229, Comprehensive Cancer Center, Institute Eugène Marquis, 35042 Rennes, France
345 Department of Nuclear Medicine, CS 44229, Comprehensive Cancer Center, Institute Eugène Marquis, F-35042 Rennes, France
346 schema:name Department of Medical Imaging, CS 44229, Comprehensive Cancer Center, Institute Eugène Marquis, 35042 Rennes, France
347 Department of Medical Informatics, CS 44229, Comprehensive Cancer Center, Institute Eugène Marquis, 35042 Rennes, France
348 Department of Medical Oncology, CS 44229, Comprehensive Cancer Center, Institute Eugène Marquis, 35042 Rennes, France
349 Department of Nuclear Medicine, CS 44229, Comprehensive Cancer Center, Institute Eugène Marquis, F-35042 Rennes, France
350 INSERM, U-991, Liver Metabolisms and Cancer, F-35033 Rennes, France
351 University of Rennes 1, F-35043 Rennes, France
352 rdf:type schema:Organization
353 grid-institutes:grid.462725.0 schema:alternateName INSERM, U-991, Liver Metabolisms and Cancer, F-35033 Rennes, France
354 schema:name Department of Nuclear Medicine, CS 44229, Comprehensive Cancer Center, Institute Eugène Marquis, F-35042 Rennes, France
355 INSERM, U-991, Liver Metabolisms and Cancer, F-35033 Rennes, France
356 University of Rennes 1, F-35043 Rennes, France
357 rdf:type schema:Organization
358 grid-institutes:grid.462844.8 schema:alternateName University of Pierre et Marie Curie, 75005 Paris, France
359 schema:name University of Pierre et Marie Curie, 75005 Paris, France
360 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...